Literature DB >> 18827717

Brain imaging in pediatric obsessive-compulsive disorder.

Frank P MacMaster1, Joseph O'Neill, David R Rosenberg.   

Abstract

OBJECTIVE: To review progress in understanding pediatric obsessive-compulsive disorder (OCD). The focus is on the frontal-striatal-thalamic model of OCD, neurobiological and genetic studies of the disorder, and their influence on recent advances in treatment.
METHOD: Computerized literature searches were conducted with the key words "obsessive-compulsive disorder" in conjunction with "pediatric," "genetics," and "imaging."
RESULTS: Neuroimaging studies find evidence to support the frontal-striatal-thalamic model. Genetic and neurochemical studies also implicate glutamate in the pathological finding of OCD. This has led to the application of glutamate-modulating agents to treat OCD.
CONCLUSIONS: Studies of pediatric OCD have led to a refined frontal-striatal-thalamic model of pathogenesis and are having an evidence-based impact on treatment. Despite this progress, fully explanatory models are still needed that would allow for accurate prognosis and the development of targeted and efficacious treatments.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18827717      PMCID: PMC2696312          DOI: 10.1097/CHI.0b013e318185d2be

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  91 in total

1.  Proton spectroscopic imaging of the thalamus in treatment-naive pediatric obsessive-compulsive disorder.

Authors:  K D Fitzgerald; G J Moore; L A Paulson; C M Stewart; D R Rosenberg
Journal:  Biol Psychiatry       Date:  2000-02-01       Impact factor: 13.382

2.  Molecular analysis of system N suggests novel physiological roles in nitrogen metabolism and synaptic transmission.

Authors:  F A Chaudhry; R J Reimer; D Krizaj; D Barber; J Storm-Mathisen; D R Copenhagen; R H Edwards
Journal:  Cell       Date:  1999-12-23       Impact factor: 41.582

3.  Pituitary volume in treatment-naïve pediatric major depressive disorder.

Authors:  Frank P MacMaster; Aileen Russell; Yousha Mirza; Matcheri S Keshavan; S Preeya Taormina; Rashmi Bhandari; Courtney Boyd; Michelle Lynch; Michelle Rose; Jennifer Ivey; Gregory J Moore; David R Rosenberg
Journal:  Biol Psychiatry       Date:  2006-07-28       Impact factor: 13.382

4.  Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine.

Authors:  A R Gilbert; G J Moore; M S Keshavan; L A Paulson; V Narula; F P Mac Master; C M Stewart; D R Rosenberg
Journal:  Arch Gen Psychiatry       Date:  2000-05

5.  Effects of riluzole on electrically evoked neurotransmitter release.

Authors:  T Jehle; J Bauer; E Blauth; A Hummel; M Darstein; T M Freiman; T J Feuerstein
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

6.  Cloning and functional identification of a neuronal glutamine transporter.

Authors:  H Varoqui; H Zhu; D Yao; H Ming; J D Erickson
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

7.  Thalamic volume in pediatric obsessive-compulsive disorder patients before and after cognitive behavioral therapy.

Authors:  D R Rosenberg; N R Benazon; A Gilbert; A Sullivan; G J Moore
Journal:  Biol Psychiatry       Date:  2000-08-15       Impact factor: 13.382

8.  Gray matter structural alterations in psychotropic drug-naive pediatric obsessive-compulsive disorder: an optimized voxel-based morphometry study.

Authors:  Philip R Szeszko; Christopher Christian; Frank Macmaster; Todd Lencz; Yousha Mirza; S Preeya Taormina; Phillip Easter; Michelle Rose; G A Michalopoulou; David R Rosenberg
Journal:  Am J Psychiatry       Date:  2008-04-15       Impact factor: 18.112

9.  Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder.

Authors:  Murat Yücel; Stephen J Wood; R Mark Wellard; Ben J Harrison; Alex Fornito; Jesus Pujol; Dennis Velakoulis; Christos Pantelis
Journal:  Aust N Z J Psychiatry       Date:  2008-06       Impact factor: 5.744

10.  Gray matter differences between pediatric obsessive-compulsive disorder patients and high-risk siblings: a preliminary voxel-based morphometry study.

Authors:  Andrew R Gilbert; Matcheri S Keshavan; Vaibhav Diwadkar; Jeffrey Nutche; Frank Macmaster; Phillip C Easter; Christian J Buhagiar; David R Rosenberg
Journal:  Neurosci Lett       Date:  2008-02-12       Impact factor: 3.046

View more
  30 in total

1.  Glutamate in Pediatric Obsessive-Compulsive Disorder and Response to Cognitive-Behavioral Therapy: Randomized Clinical Trial.

Authors:  Joseph O'Neill; John Piacentini; Susanna Chang; Ronald Ly; Tsz M Lai; Casey C Armstrong; Lindsey Bergman; Michelle Rozenman; Tara Peris; Allison Vreeland; Ross Mudgway; Jennifer G Levitt; Noriko Salamon; Stefan Posse; Gerhard S Hellemann; Jeffry R Alger; James T McCracken; Erika L Nurmi
Journal:  Neuropsychopharmacology       Date:  2017-04-04       Impact factor: 7.853

Review 2.  Neural substrates of childhood anxiety disorders: a review of neuroimaging findings.

Authors:  Jennifer Urbano Blackford; Daniel S Pine
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2012-06-04

3.  MRSI correlates of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder.

Authors:  Joseph O'Neill; John C Piacentini; Susanna Chang; Jennifer G Levitt; Michelle Rozenman; Lindsey Bergman; Noriko Salamon; Jeffry R Alger; James T McCracken
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2011-10-01       Impact factor: 5.067

Review 4.  Rodent models of obsessive compulsive disorder: Evaluating validity to interpret emerging neurobiology.

Authors:  Isaac Zike; Tim Xu; Natalie Hong; Jeremy Veenstra-VanderWeele
Journal:  Neuroscience       Date:  2016-09-16       Impact factor: 3.590

5.  12-week, placebo-controlled trial of add-on riluzole in the treatment of childhood-onset obsessive-compulsive disorder.

Authors:  Paul J Grant; Lisa A Joseph; Cristan A Farmer; David A Luckenbaugh; Lorraine C Lougee; Carlos A Zarate; Susan E Swedo
Journal:  Neuropsychopharmacology       Date:  2013-12-19       Impact factor: 7.853

Review 6.  Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V.

Authors:  James F Leckman; Damiaan Denys; H Blair Simpson; David Mataix-Cols; Eric Hollander; Sanjaya Saxena; Euripedes C Miguel; Scott L Rauch; Wayne K Goodman; Katharine A Phillips; Dan J Stein
Journal:  Depress Anxiety       Date:  2010-06       Impact factor: 6.505

7.  Gray matter volumes in obsessive-compulsive disorder before and after fluoxetine or cognitive-behavior therapy: a randomized clinical trial.

Authors:  Marcelo Queiroz Hoexter; Fábio Luis de Souza Duran; Carina Chaubet D'Alcante; Darin Dean Dougherty; Roseli Gedanke Shavitt; Antonio Carlos Lopes; Juliana Belo Diniz; Thilo Deckersbach; Marcelo Camargo Batistuzzo; Rodrigo Affonseca Bressan; Euripedes Constantino Miguel; Geraldo Filho Busatto
Journal:  Neuropsychopharmacology       Date:  2011-10-26       Impact factor: 7.853

8.  Effects of intensive cognitive-behavioral therapy on cingulate neurochemistry in obsessive-compulsive disorder.

Authors:  Joseph O'Neill; Eda Gorbis; Jamie D Feusner; Jenny C Yip; Susanna Chang; Karron M Maidment; Jennifer G Levitt; Noriko Salamon; John M Ringman; Sanjaya Saxena
Journal:  J Psychiatr Res       Date:  2013-01-04       Impact factor: 4.791

9.  Glutamate system genes and brain volume alterations in pediatric obsessive-compulsive disorder: a preliminary study.

Authors:  Ke Wu; Gregory L Hanna; Philip Easter; James L Kennedy; David R Rosenberg; Paul D Arnold
Journal:  Psychiatry Res       Date:  2012-11-13       Impact factor: 3.222

10.  Orbital frontal cortex in treatment-naïve pediatric obsessive-compulsive disorder.

Authors:  Frank Macmaster; Anvi Vora; Phillip Easter; Carrie Rix; David Rosenberg
Journal:  Psychiatry Res       Date:  2010-01-13       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.